Showing results (351-360 of 974) with videos related to

Sort By:
Pageof 98
JCO Clinical Cancer Informatics|May 5, 2025
Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in CirrhosisJeremy Louissaint, Beverly Kyalwazi, John Deng, et al.
Medical Care|January 25, 2021
Reimbursement Matters: Overcoming Barriers to Clinical Trial AccrualSimon J Craddock Lee, Caitlin C Murphy, David E Gerber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2013
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancerHak Choy, Lee S Schwartzberg, Shaker R Dakhil, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2015
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)Taofeek K Owonikoko, Suzanne E Dahlberg, Saad A Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2020
Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research AdjustmentsDavid E Gerber, Thomas Y Sheffield, M Shaalan Beg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung CancersEdward A Motea, Xiumei Huang, Naveen Singh, et al.
Science Translational Medicine|October 3, 2014
Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndromeHans T Bjornsson, Joel S Benjamin, Li Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancersHelena A Yu, Myung-Ju Ahn, Byoung Chul Cho, et al.
The Oncologist|March 28, 2025
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancerMitchell S von Itzstein, Sawsan Rashdan, Suzanne E Dahlberg, et al.
Nature Communications|January 19, 2025
Identification of a binding site for small molecule inhibitors targeting human TRPM4Babatunde Ekundayo, Prakash Arullampalam, Christian E Gerber, et al.
Pageof 98